| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2578679 | Thérapie | 2015 | 7 Pages |
Abstract
In this pilot study, the revaluation in accordance with the recommendations of the Haute autorité de santé (HAS) led to the discontinuation of two third of anti-dementia drugs. Safety of sudden discontinuation of MSD remains to be studied.
Keywords
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Laure Peyro Saint-Paul, Jocelyne Martin, Cathy Gaillard, Aline Garnier, Brigitte Mosquet, Jean-Sébastien Guillamo, Jean-Jacques Parienti,